288 related articles for article (PubMed ID: 31883833)
1. Tumor-derived CCL20 affects B16 melanoma growth in mice.
Martin-Garcia D; Silva-Vilches C; Will R; Enk AH; Lonsdorf AS
J Dermatol Sci; 2020 Jan; 97(1):57-65. PubMed ID: 31883833
[TBL] [Abstract][Full Text] [Related]
2. The CCL20-CCR6 Axis in Cancer Progression.
Kadomoto S; Izumi K; Mizokami A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869
[TBL] [Abstract][Full Text] [Related]
3. PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment.
Liu Y; Wei D; Deguchi Y; Xu W; Tian R; Liu F; Xu M; Mao F; Li D; Chen W; Valentin LA; Deguchi E; Yao JC; Shureiqi I; Zuo X
Gastric Cancer; 2023 Nov; 26(6):904-917. PubMed ID: 37572185
[TBL] [Abstract][Full Text] [Related]
4. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis.
Nakayama T; Fujisawa R; Yamada H; Horikawa T; Kawasaki H; Hieshima K; Izawa D; Fujiie S; Tezuka T; Yoshie O
Int Immunol; 2001 Jan; 13(1):95-103. PubMed ID: 11133838
[TBL] [Abstract][Full Text] [Related]
5. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
[TBL] [Abstract][Full Text] [Related]
6. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
[TBL] [Abstract][Full Text] [Related]
7. The relationship between CCR6 and its binding partners: does the CCR6-CCL20 axis have to be extended?
Lee AY; Phan TK; Hulett MD; Körner H
Cytokine; 2015 Mar; 72(1):97-101. PubMed ID: 25585877
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
Kirshberg S; Izhar U; Amir G; Demma J; Vernea F; Beider K; Shlomai Z; Wald H; Zamir G; Shapira OM; Peled A; Wald O
PLoS One; 2011; 6(9):e24856. PubMed ID: 21949768
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.
Hammerich L; Bangen JM; Govaere O; Zimmermann HW; Gassler N; Huss S; Liedtke C; Prinz I; Lira SA; Luedde T; Roskams T; Trautwein C; Heymann F; Tacke F
Hepatology; 2014 Feb; 59(2):630-42. PubMed ID: 23959575
[TBL] [Abstract][Full Text] [Related]
10. CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma.
Samaniego R; Gutiérrez-González A; Gutiérrez-Seijo A; Sánchez-Gregorio S; García-Giménez J; Mercader E; Márquez-Rodas I; Avilés JA; Relloso M; Sánchez-Mateos P
Cancer Immunol Res; 2018 Mar; 6(3):267-275. PubMed ID: 29362221
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.
Rutihinda C; Haroun R; Saidi NE; Ordoñez JP; Naasri S; Lévesque D; Boisvert FM; Fortier PH; Belzile M; Fradet L; Hubert-Tremblay V; Turgeon GA; Wang CS; Delage P; Rousseau É; Paquette B; Oweida AJ
Cancer Immunol Immunother; 2023 May; 72(5):1089-1102. PubMed ID: 36326893
[TBL] [Abstract][Full Text] [Related]
12. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.
Homey B; Dieu-Nosjean MC; Wiesenborn A; Massacrier C; Pin JJ; Oldham E; Catron D; Buchanan ME; Müller A; deWaal Malefyt R; Deng G; Orozco R; Ruzicka T; Lehmann P; Lebecque S; Caux C; Zlotnik A
J Immunol; 2000 Jun; 164(12):6621-32. PubMed ID: 10843722
[TBL] [Abstract][Full Text] [Related]
14. CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice.
Doucet M; Jayaraman S; Swenson E; Tusing B; Weber KL; Kominsky SL
J Bone Miner Res; 2016 Jul; 31(7):1381-90. PubMed ID: 26890063
[TBL] [Abstract][Full Text] [Related]
15. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.
Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS
PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282
[TBL] [Abstract][Full Text] [Related]
16. CCL20 Signaling in the Tumor Microenvironment.
Chen W; Qin Y; Liu S
Adv Exp Med Biol; 2020; 1231():53-65. PubMed ID: 32060846
[TBL] [Abstract][Full Text] [Related]
17. CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues.
Sisirak V; Vey N; Vanbervliet B; Duhen T; Puisieux I; Homey B; Bowman EP; Trinchieri G; Dubois B; Kaiserlian D; Lira SA; Puisieux A; Blay JY; Caux C; Bendriss-Vermare N
Blood; 2011 Nov; 118(19):5130-40. PubMed ID: 21937703
[TBL] [Abstract][Full Text] [Related]
18. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
[TBL] [Abstract][Full Text] [Related]
19. CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis.
Williams IR
Ann N Y Acad Sci; 2006 Aug; 1072():52-61. PubMed ID: 17057190
[TBL] [Abstract][Full Text] [Related]
20. The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology.
Lee AYS; Körner H
Immunobiology; 2019 May; 224(3):449-454. PubMed ID: 30772094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
